The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of cobimetinib (C) combined with vemurafenib (V) in patients (pts) with BRAFV600 mutation–positive metastatic melanoma: analysis from the 4-year extended follow-up of the phase 3 coBRIM study.
 
Brigitte Dreno
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Paolo Antonio Ascierto
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Incyte; MedImmune; Merck Serono; Merck Sharp & Dohme; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Syndax
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
 
Grant A. McArthur
Research Funding - Amgen (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Novartis/Pfizer (Inst)
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Gabriella Liszkay
No Relationships to Disclose
 
Anna Maria Di Giacomo
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Mario Mandalà
No Relationships to Disclose
 
Lev V. Demidov
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Luc Thomas
No Relationships to Disclose
 
Luis De la Cruz-Merino
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Caroline Dutriaux
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Claus Garbe
Honoraria - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche
 
Isabelle Anne Rooney
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Research Funding - Roche/Genentech
 
Jessie J. Hsu
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Erica Park
Employment - Genentech
Stock and Other Ownership Interests - Roche; Roche (I)
Travel, Accommodations, Expenses - Genentech
 
Antoni Ribas
Stock and Other Ownership Interests - Advaxis; Arcus Biosciences; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; PACT Pharma; Tango Therapeutics
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck; Novartis
 
James M. G. Larkin
Honoraria - Bristol-Myers Squibb; Eisai; EUSA Pharma; GlaxoSmithKline; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sectra
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EUSA Pharma; GlaxoSmithKline; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sectra
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer; Roche/Genentech